Because BCL3 stimulates cell-cycle progression in a breast cancer cell line [30,31], and cell-cycle enhancement stimulates EGC formation [5, 6], BCL3 likely enhances PGC reprogramming via cell-cycle control. Here, BCL3 is linked to breast cancer.